Category: Danaher Corp.Syndicate content

Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit

November 8, 2013 by Brad Perriello

Danaher Corp. and private equity behemoth Blackstone are joining forces in the hunt for Johnson & Johnson's Ortho Clinical Diagnostics unit, anonymous sources tell Reuters.

Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit

Danaher climbs on Q3 numbers

October 17, 2013 by Brad Perriello

Shares of Danaher Corp. rise after it beats Wall Street's earnings forecast and affirms its outlook for the rest of the year.

Danaher climbs on Q3 numbers

Danaher (NYSE:DHR) shares gained today after the conglomerate shattered Wall Street's 3rd-quarter earnings expectations and affirmed its outlook for the balance of 2013.

Johnson & Johnson shops Ortho Clinical Diagnostics unit

September 9, 2013 by Brad Perriello

Johnson & Johnson puts its Ortho Clinical Diagnostics blood testing business on the auction block.

Johnson & Johnson shops Ortho Clinical Diagnostics unit

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Danaher slides on narrowed outlook

July 18, 2013 by Brad Perriello

Share of Danaher Corp. are down today after the company reports 2nd-quarter results and narrows its earnings forecast for the rest of the year.

Danaher slides on narrowed outlook

Danaher (NYSE:DHR) shares are down today on a narrowed earnings outlook for the rest of the year, after the conglomerate reported modest 2nd-quarter sales and earnings growth.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Danaher shares drop as Q1 earnings fall short of expectations

April 18, 2013 by Arezu Sarvestani

Danaher posts adjusted per-share earnings just a penny shy of Wall Street's consensus estimate, and the company's shares lose 2.5%.

Danaher logo

Washington-based Danaher (NYSE:DHR) posted gains in its 1st-quarter 2013 sales and profits, but fell a penny short of analysts' earning expectations for the 3 months ended March 29, 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Danaher posts wins across the board for Q4 and full-year 2012

January 29, 2013 by MassDevice staff

Danaher sees healthy sales growth across all business segments and beats analysts' expectations for the 4th quarter of 2012.

Danaher logo

Science and technology company Danaher (NYSE:DHR) posted increases across the board in its latest financial report detailing operations during the 4th quarter and full year of 2012.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Imaging agent maker Shine Medical raises $11M | Wall Street Beat

October 19, 2012 by MassDevice staff

Shine Medical raises $11 million for its alternative, non-nuclear method of creating imaging agents.

MassDevice.com Wall Street Beat

Shine Medical closed an $11.4 million funding round for its method of generating a low-energy neutron source for medical imaging that uses a particle accelerator instead of a nuclear reactor.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp